Diagnosis and treatment of obsessive-compulsive disorder and related disorders

被引:32
作者
Dell'Osso, B.
Altamura, A. C.
Mundo, E.
Marazziti, D.
Hollander, E.
机构
[1] CUNY Mt Sinai Sch Med, Dept Psychiat, Compuls Impuls & Anxiety Disorders Program, New York, NY 10029 USA
[2] Univ Milan, Dipartimento Sci Clin Luigi Sacco, Dipartimento Psichiatria, Milan, Italy
[3] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, Pisa, Italy
关键词
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTRAVENOUS CLOMIPRAMINE; REUPTAKE INHIBITORS; FLUOXETINE; THERAPY; FLUVOXAMINE; EXPOSURE;
D O I
10.1111/j.1742-1241.2006.01167.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obsessive-compulsive disorder (OCD) is currently recognised as one of the most common psychiatric disorders as well as one of the most disabling of all medical disorders. Obsessive-compulsive related disorders (OCRDs), often comorbid with OCD, include many distinct psychiatric conditions (i.e. some somatoform disorders, eating disorders, impulse control disorders and some neurological conditions) which have overlapping symptoms and compulsive qualities with OCD. Although effective treatments exist, OCD and related disorders are often underdiagnosed and undertreated. Serotonin reuptake inhibitors (SRIs) and cognitive behavioural therapy (CBT) represent the first-line treatment for OCD and related disorders. However, the time and the doses of the medications used in the treatment of OCD and related disorders differ from those recommended in depressive disorders. In addition, remission is not common for patients with OCD and related disorders in clinical practice, and poor responders as well as refractory cases may benefit from different treatment strategies including integrated treatment, pharmacological augmentation and brain stimulation techniques.
引用
收藏
页码:98 / 104
页数:7
相关论文
共 43 条
[1]  
American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU
[2]  
BERNABID AL, 1991, LANCET, V337, P402
[3]  
BISSERBE JC, 1997, EUR PSYCHIAT, V153, P1450
[4]  
Bystritsky A, 1996, PSYCHIATR SERV, V47, P170
[5]  
CALVOCORESSI L, 1995, AM J PSYCHIAT, V152, P441
[6]   Brain stimulation techniques in the treatment of obsessive-compulsive disorder: Current and future directions [J].
Dell'Osso, B ;
Altamura, AC ;
Allen, A ;
Hollander, E .
CNS SPECTRUMS, 2005, 10 (12) :966-+
[7]   Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review [J].
Dell'Osso, Bernardo ;
Nestadt, Gerald ;
Allen, Andrea ;
Hollander, Eric .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) :600-610
[8]  
DELLOSSO B, 2005, CLIN PRACT EPIDEMIOL, V10, P1
[9]  
DELLOSSO B, 2006, EUR ARCH PSYCHI 0907
[10]  
DEVEAUGHGEISS J, 1991, ARCH GEN PSYCHIAT, V48, P730